Specifically, understanding aberrant 5hmC changes in RAP1B and other genes enriches our understanding of the molecular mechanisms driving lung cancer tumorigenesis, paving the way for novel targeted therapeutic approaches. This evidence concerns the gene RAP1B and lung cancer.